This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Cerebellar haemangioblastoma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A haemangioblastoma is a tumour of vascular origin which occurs primarily in young and middle aged adults, slightly more often in males. Typically, it presents as a cystic swelling in one or more cerebellar hemispheres, but it may present in the retina, spinal cord and other sites. Occasionally, they may be multiple. They may be associated with other pathologies such as polycythaemia and cystic lesions in other tissues such as in von Hippel Lindau disease.

Presentation is characteristically one of a rapid evolution of cerebellar disturbance with raised intracranial pressure. Subarachnoid haemorrhage may occur. In females, onset may be coincident with pregnancy. The tumour is revealed on CT as a well defined, low density cystic lesion with a strong enhancing nodule in the wall. Angiography helps differentiate multiple tumours from multiple metastases.

Treatment is by excision. The recurrence rate is 20%.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.